Hello everybody,
My name is Matt and I work with AGTC ( http://www.agtc.com/ ). You may already know that AGTC is developing gene therapies for the treatment of conditions including X-linked retinoschisis (XLRS) and achromatopsia (ACHM) caused by mutations in the CNGB3 gene.
We thought you may be interested to learn that AGTC is currently seeking participants for its gene therapy clinical studies for the treatment of XLRS and ACHM.
If you or anyone you know is interested in learning more about these trials, including information about who qualifies to join the trial[s], please visit agtc.com/patients-and-caregivers or email us at jdolgin@agtc.com.
Please don’t hesitate to email us with any questions.
Find out more about AGTC at www.agtc.com, and you can also find AGTC on Twitter ( www.twitter.com/agtc_ ), Facebook [ www.facebook.com/AppliedGeneticTechnologiesCorporation ] and YouTube [ www.youtube.com/channel/UC8ClmLoa2PKz2M5lM2gWoOQ ].
Thank you,
Matt